Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP380945.RAYzXB3QHuhPs_Aka196-LuwNkK_DOXpcWiSpF4ISvXsk130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380945.RAYzXB3QHuhPs_Aka196-LuwNkK_DOXpcWiSpF4ISvXsk130_provenance.
• assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_provenance.
• NP1154452.RAQndnxotgQSnt9npflwfMeDJ7mK3hJWD-HEBIj-CZvYo130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154452.RAQndnxotgQSnt9npflwfMeDJ7mK3hJWD-HEBIj-CZvYo130_provenance.
• NP838094.RAtkgpBMf9WtyxTbKU7BERKqKwFhlMh-ex2nLeoIO0N-M130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838094.RAtkgpBMf9WtyxTbKU7BERKqKwFhlMh-ex2nLeoIO0N-M130_provenance.
• NP380777.RA6gLjCIY6pI2z41wfHPKbl1FA_krY5JtMSzVAX8ZmJSs130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380777.RA6gLjCIY6pI2z41wfHPKbl1FA_krY5JtMSzVAX8ZmJSs130_provenance.
• NP838087.RAIPmGpLMAkcMOrsExiiZF6vEttupS5wIc020TbB95xrE130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838087.RAIPmGpLMAkcMOrsExiiZF6vEttupS5wIc020TbB95xrE130_provenance.
• NP1154451.RAJKtQPu61kIBFXbLLgHOSNGKUpmYUZTWQQqlk_IcRrdY130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154451.RAJKtQPu61kIBFXbLLgHOSNGKUpmYUZTWQQqlk_IcRrdY130_provenance.
• NP1154449.RA8Zlv8wmyZ6Iv5TVasfodoVbXsb-EAOYeTDlvWeec2Iw130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154449.RA8Zlv8wmyZ6Iv5TVasfodoVbXsb-EAOYeTDlvWeec2Iw130_provenance.